EcoDrugPlus

Solute Carrier Family 6 Member 4a

Ensembl ID : ENSOMYG00000045678
Gene Symbol: SLC6A4A
1 Cross references
195 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSOMYG00000054672
Gene Symbol: SLC6A9
1 Cross references
202 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSOMYG00000018126
Gene Symbol: SLC6A9
1 Cross references
202 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSOMYG00000036963
Gene Symbol: SSTR1
2 Cross references
152 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSOMYG00000050236
Gene Symbol: SSTR1
1 Cross references
151 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSOMYG00000058555
Gene Symbol: SSTR2
1 Cross references
186 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSOMYG00000033190
Gene Symbol: SSTR2
1 Cross references
186 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSOMYG00000012694
Gene Symbol: SSTR3
1 Cross references
183 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSOMYG00000003345
Gene Symbol: SYK
1 Cross references
200 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2a

Ensembl ID : ENSOMYG00000059641
Gene Symbol: SRD5A2A
1 Cross references
202 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2a

Ensembl ID : ENSOMYG00000026540
Gene Symbol: SRD5A2A
1 Cross references
202 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2b

Ensembl ID : ENSOMYG00000005932
Gene Symbol: SRD5A2B
1 Cross references
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).